CVS-Aetna deal sidesteps one antitrust hurdle: 5 things to know

(By Alia Paavola for Becker’s Hospital Review)

In its attempt to purchase health insurer Aetna for $69 billion, CVS Health has effectively dodged one antitrust hurdle because regulators don’t see competitive problems from joining two companies that operate at different levels of the supply chain, according to Bloomberg. Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.